肿瘤电场治疗仪

Search documents
进入创新通道!肿瘤电场治疗仪 | 附赛道分析
思宇MedTech· 2025-08-16 02:16
预报名福利: 第三届全球手术机器人大会 预报名:2025医疗器械研发创新论坛(上海) 2025年8月5日,国家药品监督管理局公布《创新医疗器械特别审查申请审查结果公示(2025年第7号)》,共有10款产品进入创新通道,其中包括 Novocure 诺沃 库勒有限责任公司 的 肿瘤电场治疗仪 。 前序文章: 背"书包"治疗癌症?看似"大忽悠"实则黑科技肿瘤电场疗法 融资数千万!肿瘤电场治疗仪 据思宇MedTech所知, 目前 中国本土明确布局肿瘤电场治疗的企业包括 4家: 湖南安泰康成 (2020年11月进入创新通道,尚未获批,已近5年)、 江苏 海莱新 创 (2023年初进入创新通道, 尚未获批 )、 河北普尼医疗 (2023年12月 进入创新通道,尚未获批 )、 赛福凯尔(绍兴) ( 在首都医科大学附属天坛医院开 展临床 ) 。(如有更多,欢迎读者反馈) 据报道,2025年7月国内首个"肿瘤电场治疗专业委员会"正式成立。中国抗癌协会胶质瘤专委会副主委、中国医师协会胶质瘤放疗专委会副主委、复旦大学附 属华山医院放疗中心汪洋教授当选为"肿瘤电场治疗专业委员会"主任委员。 在中国,Novocure 在 2018 年 ...
最新!10款医疗器械进入创新通道!
思宇MedTech· 2025-08-05 04:18
Core Viewpoint - The article highlights the upcoming Third Global Surgical Robot Conference scheduled for September 4-5, 2025, and discusses various innovative medical devices and companies involved in the healthcare sector, particularly focusing on advancements in surgical and diagnostic technologies. Group 1: Upcoming Events - The Third Global Surgical Robot Conference will take place on September 4-5, 2025, providing opportunities for doctors, entrepreneurs, and researchers to participate and apply for individual and corporate awards [1]. Group 2: Innovative Medical Devices - Guangzhou Aiyunji Information Technology Co., Ltd. has developed an AI-assisted prenatal ultrasound diagnostic software named Aiyunzhisheng (PAICS), which is designed to enhance efficiency and reduce risks in prenatal screening [2][3]. - Hebei Ruihe Medical Device Co., Ltd. focuses on the development, production, and sales of various medical devices, holding 101 authorized patents and nearly 2000 approved products [5]. - Shanghai Yixin Medical Device Co., Ltd. has created the world's first polymer valve product, SIKELIA®, which successfully completed its first clinical implantation, marking a significant advancement in interventional treatment for valve diseases [6]. - Novocure GmbH specializes in Tumor Treating Fields (TTFields) technology, aiming to extend the survival of patients with aggressive cancers through wearable medical devices [8]. - Hangzhou Wiener Anke Medical Technology Co., Ltd. is innovating in tumor minimally invasive ablation solutions, utilizing high-pressure pulsed electric field technology [9][10]. - Shenzhen Xianjian Technology Co., Ltd. reported a total revenue of 1.304 billion RMB in 2024, with a 2.9% year-on-year growth, driven by its peripheral vascular intervention business [12]. - Suzhou Jiyin Biological Engineering Co., Ltd. has developed a tumor molecular residual disease detection kit, contributing to precision medicine and monitoring in oncology [13]. - Shanghai Shangyang Medical Technology Co., Ltd. focuses on cardiac electrophysiology pulsed electric field ablation technology and has completed a Series A financing round [14]. - Chengxing (Nantong) Medical Device Co., Ltd. specializes in heart-lung intervention devices and has developed several core products since its establishment in 2021 [15]. - Shanghai Yiyu Technology Co., Ltd. reported a revenue of approximately 528 million RMB in its structural heart disease business for 2024, reflecting a 6.4% year-on-year increase [16][17].